Selective MAO-A inhibitors are effective in the treatment of depression [15], whereas MAO-B inhibitors are useful for the treatment of depression, Alzheimer’s disease and Parkinson’s disease [11,16]. This evidence concerns the gene MAOA and depressive symptom measurement.